Table 1.
Characteristic | n | % |
---|---|---|
Age (y) | ||
Minimum | 25 | 18.12 |
Maximum | 74 | 53.62 |
Median | 47 | |
Histology | ||
Invasive ductal carcinoma | 134 | 97.10 |
Invasive lobular carcinoma | 3 | 2.17 |
Invasive papillary carcinoma | 1 | 0.72 |
Tumor location | ||
Left-sided | 73 | 52.90 |
Right-sided | 65 | 47.10 |
T stage | ||
T0 | 2 | 1.45 |
T1 | 39 | 28.26 |
T2 | 79 | 57.25 |
T3 | 11 | 7.97 |
T4 | 6 | 4.35 |
Tx | 1 | 0.72 |
N stage | ||
N0 | 6 | 4.35 |
N1 | 46 | 33.33 |
N2 | 52 | 37.68 |
N3 | 33 | 23.91 |
Nx | 1 | 0.72 |
Radiotherapy | ||
3D-CRT | 48 | 34.78 |
F-IMRT | 49 | 35.51 |
I-IMRT | 41 | 29.71 |
PTV | ||
Chest wall | 7 | 5.07 |
Chest wall+SCF | 131 | 94.93 |
SCF, supraclavicular fossa; 3D-CRT, three-dimensional conformal radiotherapy; F-IMRT, field-in-field forward intensity-modulated radiotherapy; I-IMRT, inverse IMRT.